Claim your 2-week free trial to StreetInsider Premium here. Athenex, Inc. (NASDAQ: ATNX) today announced early. Phase I and Phase II clinical studies showed excellent efficacy and safety results. After the FDA end of Phase II. About the JMSC; Message from the Director; Our story; Our home at historic Eliot Hall; Videos; Career opportunities with us; Contact the JMSC; People. Staff list A quasi-experimental study of corrections at newspapers pre-…